Vitamin D and COVID‐19 in an immunocompromised patient with multiple comorbidities—A Case Report
Abstract Routine 25‐OH‐Vitamin D3 measurement in COVID‐19 patients could be of great importance, either for clinical course estimation or deciding on supplementation.
Main Authors: | Martina Kralj, Hrvoje Jakovac |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-04-01
|
Series: | Clinical Case Reports |
Subjects: | |
Online Access: | https://doi.org/10.1002/ccr3.4010 |
Similar Items
-
Vitamin D Deficiency and Outcome of COVID-19 Patients
by: Aleksandar Radujkovic, et al.
Published: (2020-09-01) -
Vitamin D and Lung Outcomes in Elderly COVID-19 Patients
by: Alberto Sulli, et al.
Published: (2021-02-01) -
Management of COVID-19 in comorbidities
by: Chiara Cardamone, et al.
Published: (2020-12-01) -
Vitamin D and disease severity in coronavirus disease 19 (COVID-19)
by: G. Adami, et al.
Published: (2021-01-01) -
Could Vitamins Help in the Fight Against COVID-19?
by: Thomas H Jovic, et al.
Published: (2020-08-01)